Profarma Distribuidora de Produtos Farmacêuticos S.A. - Laporan Laba Rugi (TTM)

Profarma Distribuidora de Produtos Farmacêuticos S.A.
BR ˙ BOVESPA ˙ BRPFRMACNOR1
R$ 8.00 ↓ -0.03 (-0.37%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Profarma Distribuidora de Produtos Farmacêuticos S.A. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 5,281 5,481 5,579 5,891 6,199 6,413 6,661 7,031 7,435 7,816 8,087 8,291 8,550 8,662 8,889 9,038 9,345 10,154 10,613 11,033
Change (%) 3.80 1.79 5.58 5.23 3.45 3.86 5.56 5.74 5.13 3.46 2.52 3.13 1.30 2.62 1.68 3.39 8.66 4.53 3.95
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 4,521 4,718 4,801 5,046 5,324 5,506 5,720 6,013 6,348 6,671 6,889 7,075 7,299 7,370 7,558 7,657 7,906 8,631 9,023 9,395
Change (%) 4.36 1.76 5.11 5.50 3.42 3.89 5.12 5.58 5.08 3.27 2.70 3.16 0.98 2.56 1.31 3.25 9.17 4.55 4.12
% of Revenue 85.60 86.07 86.04 85.66 85.88 85.85 85.87 85.51 85.39 85.34 85.19 85.34 85.36 85.08 85.03 84.72 84.60 85.00 85.02 85.16
Gross Operating Profit 760 764 779 845 875 908 941 1,019 1,087 1,146 1,198 1,216 1,252 1,292 1,331 1,381 1,439 1,523 1,590 1,637
Change (%) 0.45 1.97 8.52 3.61 3.67 3.70 8.24 6.66 5.42 4.55 1.49 2.99 3.20 3.01 3.76 4.19 5.84 4.41 2.99
% of Revenue 14.40 13.93 13.96 14.34 14.12 14.15 14.13 14.49 14.61 14.66 14.81 14.66 14.64 14.92 14.97 15.28 15.40 15.00 14.98 14.84
SG&A 554 568 580 608 644 667 691 730 754 917 988 1,053 1,123 1,046 1,076 1,111 1,158 1,225 1,282 1,319
Change (%) 2.68 2.13 4.72 5.95 3.50 3.66 5.64 3.26 21.63 7.80 6.51 6.65 -6.80 2.80 3.28 4.28 5.74 4.67 2.89
% of Revenue 10.48 10.37 10.40 10.32 10.39 10.39 10.37 10.38 10.14 11.73 12.22 12.70 13.13 12.08 12.10 12.29 12.40 12.06 12.08 11.96
R&D
Change (%)
% of Revenue
OpEx 5,151 5,353 5,458 5,742 6,057 6,277 6,519 6,825 7,199 7,573 7,831 8,076 8,319 8,401 8,615 8,752 9,041 9,854 10,309 10,722
Change (%) 3.92 1.96 5.21 5.48 3.63 3.85 4.69 5.49 5.20 3.41 3.12 3.01 0.98 2.55 1.59 3.31 8.99 4.62 4.00
% of Revenue 97.55 97.66 97.82 97.48 97.71 97.88 97.87 97.06 96.83 96.89 96.84 97.41 97.29 96.99 96.92 96.83 96.75 97.05 97.13 97.19
Operating Income 129 128 122 149 142 136 142 207 236 243 255 215 231 261 274 286 303 300 304 310
Change (%) -0.83 -5.23 22.35 -4.44 -4.13 4.24 45.51 14.16 2.97 5.04 -15.76 7.61 12.88 4.99 4.49 5.86 -1.19 1.49 2.08
% of Revenue 2.45 2.34 2.18 2.52 2.29 2.12 2.13 2.94 3.17 3.11 3.16 2.59 2.71 3.01 3.08 3.17 3.25 2.95 2.87 2.81
Interest Expense -73 -67 -62 -64 -72 -76 -92 -116 -134 -149 -158 -160 -80 -162 -164 -158 -156 -149 -126 -168
Change (%) -7.31 -7.24 2.67 12.35 5.88 20.97 25.39 16.32 11.03 5.86 1.06 -49.87 102.33 1.02 -3.65 -1.15 -4.09 -15.86 33.74
% of Revenue -1.37 -1.23 -1.12 -1.09 -1.16 -1.19 -1.38 -1.64 -1.81 -1.91 -1.95 -1.93 -0.94 -1.87 -1.84 -1.74 -1.67 -1.47 -1.18 -1.52
Net Income 44 52 60 99 95 78 63 96 87 81 82 31 47 70 77 91 107 115 125 118
Change (%) 18.89 15.50 63.12 -3.79 -17.57 -19.37 51.53 -8.61 -7.37 1.54 -62.60 51.54 51.24 9.53 17.48 18.61 6.64 8.70 -5.25
% of Revenue 0.83 0.95 1.08 1.67 1.53 1.22 0.95 1.36 1.17 1.03 1.02 0.37 0.54 0.81 0.87 1.00 1.15 1.13 1.17 1.07

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista